Literature DB >> 16406780

Sticky connections: extracellular matrix protein recognition and integrin-mediated cellular invasion by Staphylococcus aureus.

Christof R Hauck1, Knut Ohlsen.   

Abstract

Staphylococcus aureus is a leading cause of hospital-acquired and often persistent infections. A key feature of pathogenic S. aureus is the expression of an array of extracellular matrix-binding proteins. In particular, the fibronectin-binding proteins FnBP-A and FnBP-B afford the pathogen the ability to connect to cellular integrins and to trigger internalization into host cells. Recent work has highlighted the role of host cell invasion in the pathogenesis of S. aureus, the structure-function relationship of FnBPs, and the host factors required to allow bacterial uptake. Understanding the invasive capacity of S. aureus should open up new avenues to control this microorganism in diverse disease settings.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16406780     DOI: 10.1016/j.mib.2005.12.002

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  51 in total

1.  Role of fibronectin-binding proteins A and B in in vitro cellular infections and in vivo septic infections by Staphylococcus aureus.

Authors:  Hitomi Shinji; Yukio Yosizawa; Akiko Tajima; Tadayuki Iwase; Shinya Sugimoto; Keiko Seki; Yoshimitsu Mizunoe
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

2.  MgrA Governs Adherence, Host Cell Interaction, and Virulence in a Murine Model of Bacteremia Due to Staphylococcus aureus.

Authors:  Liang Li; Genzhu Wang; Ambrose Cheung; Wessam Abdelhady; Kati Seidl; Yan Q Xiong
Journal:  J Infect Dis       Date:  2019-08-09       Impact factor: 5.226

3.  Staphylococcus aureus induces hypoxia and cellular damage in porcine dermal explants.

Authors:  Abdul G Lone; Erhan Atci; Ryan Renslow; Haluk Beyenal; Susan Noh; Boel Fransson; Nehal Abu-Lail; Jeong-Jin Park; David R Gang; Douglas R Call
Journal:  Infect Immun       Date:  2015-04-06       Impact factor: 3.441

4.  The comparison of antimicrobial effectiveness of contact lens solutions.

Authors:  Ali Kal; Mustafa Ilker Toker; Serpil Kaya
Journal:  Int Ophthalmol       Date:  2016-10-13       Impact factor: 2.031

5.  Immunorelevant proteins for the diagnosis of bovine staphylococcal mastitis.

Authors:  M H Fabres-Klein; R C Klein; S O De Paula; A O B Ribon
Journal:  World J Microbiol Biotechnol       Date:  2013-02-06       Impact factor: 3.312

6.  Simvastatin inhibits Staphylococcus aureus host cell invasion through modulation of isoprenoid intermediates.

Authors:  Mary P Horn; Sharmon M Knecht; Frances L Rushing; Julie Birdsong; C Parker Siddall; Charron M Johnson; Terri N Abraham; Amy Brown; Catherine B Volk; Kelly Gammon; Derron L Bishop; John L McKillip; Susan A McDowell
Journal:  J Pharmacol Exp Ther       Date:  2008-04-03       Impact factor: 4.030

7.  Interferon-γ enhances both the anti-bacterial and the pro-inflammatory response of human mast cells to Staphylococcus aureus.

Authors:  Emily J Swindle; Jared M Brown; Madeleine Rådinger; Frank R DeLeo; Dean D Metcalfe
Journal:  Immunology       Date:  2015-10-05       Impact factor: 7.397

8.  Genetic evidence for an alternative citrate-dependent biofilm formation pathway in Staphylococcus aureus that is dependent on fibronectin binding proteins and the GraRS two-component regulatory system.

Authors:  Robert M Q Shanks; Michael A Meehl; Kimberly M Brothers; Raquel M Martinez; Niles P Donegan; Martha L Graber; Ambrose L Cheung; George A O'Toole
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

9.  Binding and activation of host plasminogen on the surface of Francisella tularensis.

Authors:  Shawn R Clinton; James E Bina; Thomas P Hatch; Michael A Whitt; Mark A Miller
Journal:  BMC Microbiol       Date:  2010-03-12       Impact factor: 3.605

Review 10.  Interaction of staphylococci with bone.

Authors:  John A Wright; Sean P Nair
Journal:  Int J Med Microbiol       Date:  2009-11-03       Impact factor: 3.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.